Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-26 15:08:40 ET
Novavax, Inc. (NVAX) Q4 2025 Earnings Call February 26, 2026 8:30 AM EST
Company Participants
Luis Sanay - Vice President of Investor Relations
John Jacobs - President, CEO & Director
Elaine O'Hara - Executive VP & Chief Strategy Officer
Ruxandra Draghia-Akli - Executive VP and Head of Research & Development
James Kelly - Executive VP, CFO & Treasurer
...
Read the full article on Seeking Alpha
For further details see:
Novavax, Inc. (NVAX) Q4 2025 Earnings Call Transcript
Novavax Inc.
NASDAQ: NVAX
NVAX Trading
-0.35% G/L:
$9.6701 Last:
2,073,372 Volume:
$9.56 Open:
NVAX Latest News
February 26, 2026 08:42:07 pm
Power Hour Surge: Quantum Breakouts, Biotech Visibility, and Crypto Strategy Running into the Close
February 26, 2026 08:00:00 am
Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
February 19, 2026 08:00:00 am
Novavax to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
NVAX Stock Data
$1,428,366,166
160,874,005
0.11%
93
N/A
Biotechnology & Life Sciences
Healthcare
US
Gaithersburg
